NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of…Read More

You might also be interested in reading Bitcoin price will likely shrug off $530M GBTC unlock in July — analysis.